UPDATED: Ranbaxy matter sparks backlash years after first being uncovered

Eric Palmer

Laboratories' entanglements with the FDA and federal authorities for foisting adulterated drugs on consumers and then lying to cover it up have been an escalating story since 2008. But its felony pleas and $ 500 million settlement two weeks ago are serving up more consumer-level than in any of the 5 years since the surfaced.

FiercePharma News

Share This Post

Related Articles

Leave a Reply

© 2019 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS